---
title: "PCI improves angina symptoms without medication in ORBITA-2 trial"
date: "2023-11-13T09:56:34.000Z"
publishedDate: "13 novembre 2023"
summary: "Percutaneous coronary intervention (PCI) relieves stable chest pain and improves exercise capacity among patients taking little or no chest pain medication, research presented at the American Heart Association’s 2023 Scientific Sessions (11–13 November, Philadelphia, USA) has shown. Previously, the ORBITA trial published in 2017, had shown that stenting did not improve exercise tolerance or chest pain any [&#8230;] The post PCI improves angina symptoms without medication in ORBITA-2 trial appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/orbita-2-trial-aha-2023/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2023-11-13-pci-improves-angina-symptoms-without-medication-in-orbita-2-trial"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/11/Headshot_Allamee-1.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/orbita-2-trial-aha-2023/"
---

![PCI improves angina symptoms without medication in ORBITA-2 trial](https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/11/Headshot_Allamee-1.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/orbita-2-trial-aha-2023/*

## L’essentiel

Percutaneous coronary intervention (PCI) relieves stable chest pain and improves exercise capacity among patients taking little or no chest pain medication, research presented at the American Heart Association’s 2023 Scientific Sessions (11–13 November, Philadelphia, USA) has shown. Previously, the ORBITA trial published in 2017, had shown that stenting did not improve exercise tolerance or chest pain any [&#8230;] The post PCI improves angina symptoms without medication in ORBITA-2 trial appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/orbita-2-trial-aha-2023/
